Longitudinal analysis of the evolution and dissemination of Neisseria gonorrhoeae strains (Saskatchewan, Canada, 2005 to 2008) reveals three major circulating strains and convergent evolution of ciprofloxacin and azithromycin resistance

Journal of Clinical Microbiology

Volumn 50, Issue 12, 2012, Pages 3823-3830

  Vidovic, Sinisa ^a   Thakur, Sidharath D ^a   Horsman, Greg B ^b   Levett, Paul N ^b   Anvari, Vahid ^c   Dillon, Jo Anne R ^a,c  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

^b Saskatchewan Disease Control Laboratory   (Canada)

^c UNIVERSITY OF SASKATCHEWAN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; CEFIXIME; CEFTRIAXONE; CIPROFLOXACIN; PENICILLIN G; SPECTINOMYCIN; TETRACYCLINE;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; CANADA; CLONAL VARIATION; CONVERGENT EVOLUTION; ENDEMIC DISEASE; GEOGRAPHIC DISTRIBUTION; LONGITUDINAL STUDY; MOLECULAR EVOLUTION; MULTILOCUS SEQUENCE TYPING; NEISSERIA GONORRHOEAE; NONHUMAN; NUCLEOTIDE SEQUENCE; POPULATION DISTRIBUTION; POPULATION STRUCTURE; PREVALENCE; PRIORITY JOURNAL; STRAIN DIFFERENCE;

ANTI-BACTERIAL AGENTS; AZITHROMYCIN; CIPROFLOXACIN; CLUSTER ANALYSIS; DNA, BACTERIAL; DRUG RESISTANCE, BACTERIAL; GENOTYPE; GONORRHEA; HUMANS; LONGITUDINAL STUDIES; MOLECULAR EPIDEMIOLOGY; MOLECULAR SEQUENCE DATA; MULTILOCUS SEQUENCE TYPING; NEISSERIA GONORRHOEAE; SASKATCHEWAN;

NEISSERIA GONORRHOEAE;

EID: 84869212674     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.01402-12     Document Type: Article

References (41)

1. Allen VG, et al. 2011. Molecular analysis of antimicrobial resistance mechanisms in Neisseria gonorrhoeae isolates from Ontario, Canada. Antimicrob. Agents Chemother. 55:703-12.
2. Bennett JS, et al. 2007. Species status of Neisseria gonorrhoeae: evolutionary and epidemiological inferences from multilocus sequence typing. BMC Biol. 5:35.
3. Bolan G, Ehrhardt AA, Wasserheit JN. 1999 Gender perspectives and STDs, p 117-127. In Holmes KK, Mardh PA, Sparling PF, Lemon SM, Stamm WE, Piot P, Wasserheit JN (ed), Sexually transmitted diseases, 3rd ed. McGraw-Hill, New York, NY.
4. Bolan GA, Sparling PF, Wasserheit JD. 2012. The emerging threat of untreatable gonococcal infection. N. Engl. J. Med. 366:485-487.
5. Centers for Disease Control and Prevention. 2006. Sexually transmitted diseases guidelines. MMWR Recomm. Rep. 55:1-94.
6. Centers for Disease Control and Prevention. 2007. Update to CDC's sexually transmitted diseases guidelines. Fluoroquinolones no longer recommended for treatment of gonococcal infections. MMWR Morb. Mortal. Wkly. Rep. 56:332-336.
7. Centers for Disease Control and Prevention. 2010. Gonococcal isolate surveillance project (GISP) protocol. Isolates with alert value MICs. Centers for Disease Control and Prevention, Atlanta, GA. http://www.cdc.gov/std/gisp/ GISP-Protocol07-15-2010.pdf.
8. Chisholm SA, et al. 2009. Emergence of high-level azithromycin resistance in Neisseria gonorrhoeae in England and Wales. J. Antimicrob. Chemother. 64:353-358.
9. Clinical and Laboratory Standards Institute. 2006. M7-A7. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 7th ed. Clinical and Laboratory Standards Institute, Wayne, PA.
10. Dillon JR, et al. 2001. Reduced susceptibility to azithromycin and high percentages of penicillin and tetracycline resistance in Neisseria gonorrhoeae isolates from Manaus, Brazil, 1998. Sex. Transm. Dis. 28:521-526.
11. Division of STD Prevention and Control, Health Protection Branch, Health Canada. 1998. Gonococcal infection, p 115-124. In Canadian STD guidelines. 1998 ed. Division of STD Prevention and Control, Health Protection Branch, Health Canada, Ottawa, ON, Canada.
12. Feil EJ, Li BC, Aanensen DM, Hanage WP, Spratt BG. 2004. eBURST: inferring patterns of evolutionary descent among clusters of related bacterial genotypes from multilocus sequence typing data. J. Bacteriol. 186:1518-1530. (Pubitemid 38248742)
13. Galarza PG, et al. 2009. Emergence of high level azithromycin-resistant Neisseria gonorrhoeae strains isolated in Argentina. Sex. Transm. Dis. 36:787-788.
14. Ilina NE, et al. 2010. Molecular surveillance of clinical Neisseria gonorrhoeae isolates in Russia. J. Clin. Microbiol. 48:3681-3689.
15. Martin I, Jayaraman G, Wong T, Liu G, Gilmour M, Canadian Public Health Laboratory Network. 2011. Trends in antimicrobial resistance in Neisseria gonorrhoeae isolated in Canada: 2000-2009. Sex. Transm. Dis. 38:892-898.
16. Martin I, et al. 2012. Emergence and characterization of Neisseria gonorrhoeae isolates with decreased susceptibilities to ceftriaxone and cefixime in Canada: 2001-2010. Sex. Transm. Dis. 39:316-323.
17. Mavroidi A, et al. 2011. Analysis of emergence of quinolone-resistant gonococci in Greece by combined use of Neisseria gonorrhoeae multiantigen sequence typing and multilocus sequence typing. J. Clin. Microbiol. 49:1196-1201.
18. Nei M, Kumar S. 2000. Molecular evolution and phylogenetics. Oxford University Press, New York, NY.
19. Ohnishi M, et al. 2011. Ceftriaxone-resistant Neisseria gonorrhoeae, Japan. Emerg. Infect. Dis. 17:148-149.
20. Public Health Agency of Canada. 2008. Report on sexually transmitted infections in Canada. Public Health Agency of Canada, Ottawa, ON, Canada. http://www.phac-aspc.gc.ca/std-mts/report/sti-its2008/04-eng.php.
21. Rzhetsky A, Nei M. 1992. A simple method for estimating and testing minimum evolution trees. Mol. Biol. Evol. 9:945-967.
22. Saitou N, Nei M. 1987. The neighbor-joining method: a new method for reconstructing phylogenetic trees. Mol. Biol. Evol. 4:406-425.
23. Starnino S, Stefanelli P. 2009. Azithromycin-resistant Neisseria gonorrhoeae strains recently isolated in Italy. J. Antimicrob. Chemother. 63: 1200-1204.
24. Tamura K, Nei M, Kumar S. 2004. Prospects for inferring very large phylogenies by using the neighbor-joining method. Proc. Natl. Acad. Sci. U. S. A. 101:11030-11035. (Pubitemid 38989579)
25. Tamura K, Dudley J, Nei M, Kumar S. 2007. MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0. Mol. Biol. Evol. 24:1596-1599. (Pubitemid 47236692)
26. Tazi L, et al. 2010. Population dynamics of Neisseria gonorrhoeae in Shanghai, China: a comparative study. BMC Infect. Dis. 10:13.
27. Turner CF, et al. 2002. Untreated gonococcal and chlamydial infection in a probability sample of adults. JAMA 287:726-733. (Pubitemid 34250458)
28. Unemo M, Fasth O, Fredlund H, Limnios A, Tapsall J. 2009. Phenotypic and genetic characterization of the 2008 WHO Neisseria gonorrhoeae reference strain panel intended for global quality assurance and quality control of gonococcal antimicrobial resistance surveillance for public health purposes. J. Antimicrob. Chemother. 63:1142-1151.
29. Unemo M, Golparian D, Stary A, Eigentler A. 2011. First Neisseria gonorrhoeae strain with resistance to cefixime causing gonorrhoea treatment failure in Austria, 2011. Euro Surveill. 16(43):pii:19998. http://www .eurosurveillance.org/ViewArticle.aspx?ArticleId=19998.
30. Unemo M, et al. 2011. High-level cefixime- and ceftriaxone-resistant N. gonorrhoeae in Europe (France): novel penA mosaic allele in a successful international clone causes treatment failure. Antimicrob. Agents Chemother. 56:1273-1280.
31. Unemo M, Dillon JR. 2011. Review and international recommendation of methods for typing Neisseria gonorrhoeae isolates and their implications for improved knowledge of gonococcal epidemiology, treatment, and biology. Clin. Microbiol. Rev. 24:447-458.
32. Urwin R, Maiden MCJ. 2003. Multi-locus sequence typing: a tool for global epidemiology. Trends Microbiol. 11:479-487. (Pubitemid 37214875)
33. Vidovic S, Korber D. 2006. Prevalence of Escherichia coli O157 in Saskatchewan cattle: characterization of isolates by using random amplified polymorphic DNA PCR, antibiotic resistance profiles, and pathogenicity determinants. Appl. Environ. Microbiol. 72:4347-4355. (Pubitemid 43894904)
34. Vidovic S, Horsman GB, Liao M, Dillon JR. 2011. Influence of conserved and hypervariable genetic markers on genotyping circulating strains of Neisseria gonorrhoeae. PLoS One 6:e28259. doi:10.1371/journal.pone.0028259.
35. World Health Organization. 1997. Surveillance of antibiotic susceptibility of Neisseria gonorrhoeae in the WHO western Pacific region 1992-4. WHO Western Pacific Region Gonococcal Antimicrobial Surveillance Programme. Genitourin. Med. 73:355-361.
36. World Health Organization. 2001. Prevalence and incidence in 2005 of selected sexually transmitted infections: methods and results. World Health Organization, Geneva, Switzerland.
37. World Health Organization. 2005. Surveillance of antibiotic resistance in Neisseria gonorrhoeae in the World Health Organization Western Pacific Region, 2003. Commun. Dis. Intell. 29:62-64.
38. Wylie LJ, Jolly A. 2001. Patterns of chlamydia and gonorrhea infection in sexual networks in Manitoba, Canada. Sex. Transm. Dis. 28:14-24. (Pubitemid 32064204)
39. Wylie LJ, Cabral T, Jolly AM. 2005. Identification of networks of sexually transmitted infection: a molecular, geographic, and social network analysis. J. Infect. Dis. 191:899-906. (Pubitemid 40349805)
40. Xia MS, Pang YJ, Roberts MC. 1995. Detection of two groups of 25.2 MDa Tet M plasmids by polymerase chain reaction of the downstream region. Mol. Cell. Probes 9:327-332.
41. Yang Y, et al. 2006. Antimicrobial susceptibility and molecular determinants of quinolone resistance in Neisseria gonorrhoeae isolates from Shanghai. J. Antimicrob. Chemother. 58:868-872. (Pubitemid 44390969)